21-42385547-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001256317.3(TMPRSS3):​c.447-13A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.467 in 1,611,910 control chromosomes in the GnomAD database, including 183,708 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.56 ( 26997 hom., cov: 32)
Exomes 𝑓: 0.46 ( 156711 hom. )

Consequence

TMPRSS3
NM_001256317.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -3.76

Publications

20 publications found
Variant links:
Genes affected
TMPRSS3 (HGNC:11877): (transmembrane serine protease 3) This gene encodes a protein that belongs to the serine protease family. The encoded protein contains a serine protease domain, a transmembrane domain, an LDL receptor-like domain, and a scavenger receptor cysteine-rich domain. Serine proteases are known to be involved in a variety of biological processes, whose malfunction often leads to human diseases and disorders. This gene was identified by its association with both congenital and childhood onset autosomal recessive deafness. This gene is expressed in fetal cochlea and many other tissues, and is thought to be involved in the development and maintenance of the inner ear or the contents of the perilymph and endolymph. This gene was also identified as a tumor-associated gene that is overexpressed in ovarian tumors. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jan 2012]
TMPRSS3 Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive nonsyndromic hearing loss 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 21-42385547-T-C is Benign according to our data. Variant chr21-42385547-T-C is described in ClinVar as Benign. ClinVar VariationId is 46121.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.856 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMPRSS3NM_001256317.3 linkc.447-13A>G intron_variant Intron 5 of 12 ENST00000644384.2 NP_001243246.1
TMPRSS3NM_024022.4 linkc.447-13A>G intron_variant Intron 5 of 12 NP_076927.1
TMPRSS3NM_032405.2 linkc.447-13A>G intron_variant Intron 5 of 8 NP_115781.1
TMPRSS3NM_032404.3 linkc.66-13A>G intron_variant Intron 2 of 9 NP_115780.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMPRSS3ENST00000644384.2 linkc.447-13A>G intron_variant Intron 5 of 12 NM_001256317.3 ENSP00000494414.1

Frequencies

GnomAD3 genomes
AF:
0.563
AC:
85622
AN:
151974
Hom.:
26947
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.864
Gnomad AMI
AF:
0.329
Gnomad AMR
AF:
0.503
Gnomad ASJ
AF:
0.457
Gnomad EAS
AF:
0.597
Gnomad SAS
AF:
0.513
Gnomad FIN
AF:
0.357
Gnomad MID
AF:
0.595
Gnomad NFE
AF:
0.436
Gnomad OTH
AF:
0.558
GnomAD2 exomes
AF:
0.477
AC:
119974
AN:
251424
AF XY:
0.474
show subpopulations
Gnomad AFR exome
AF:
0.876
Gnomad AMR exome
AF:
0.409
Gnomad ASJ exome
AF:
0.464
Gnomad EAS exome
AF:
0.583
Gnomad FIN exome
AF:
0.360
Gnomad NFE exome
AF:
0.439
Gnomad OTH exome
AF:
0.459
GnomAD4 exome
AF:
0.457
AC:
666423
AN:
1459818
Hom.:
156711
Cov.:
44
AF XY:
0.457
AC XY:
331939
AN XY:
726302
show subpopulations
African (AFR)
AF:
0.882
AC:
29499
AN:
33456
American (AMR)
AF:
0.419
AC:
18718
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.458
AC:
11959
AN:
26122
East Asian (EAS)
AF:
0.592
AC:
23476
AN:
39672
South Asian (SAS)
AF:
0.514
AC:
44308
AN:
86218
European-Finnish (FIN)
AF:
0.366
AC:
19525
AN:
53308
Middle Eastern (MID)
AF:
0.514
AC:
2963
AN:
5764
European-Non Finnish (NFE)
AF:
0.438
AC:
486494
AN:
1110218
Other (OTH)
AF:
0.489
AC:
29481
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
20473
40945
61418
81890
102363
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14950
29900
44850
59800
74750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.564
AC:
85733
AN:
152092
Hom.:
26997
Cov.:
32
AF XY:
0.558
AC XY:
41500
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.864
AC:
35860
AN:
41518
American (AMR)
AF:
0.502
AC:
7679
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.457
AC:
1586
AN:
3468
East Asian (EAS)
AF:
0.596
AC:
3070
AN:
5152
South Asian (SAS)
AF:
0.514
AC:
2472
AN:
4814
European-Finnish (FIN)
AF:
0.357
AC:
3778
AN:
10580
Middle Eastern (MID)
AF:
0.592
AC:
174
AN:
294
European-Non Finnish (NFE)
AF:
0.436
AC:
29623
AN:
67954
Other (OTH)
AF:
0.563
AC:
1191
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1684
3368
5052
6736
8420
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
694
1388
2082
2776
3470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.492
Hom.:
57059
Bravo
AF:
0.585
Asia WGS
AF:
0.608
AC:
2116
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 23, 2009
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Dec 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autosomal recessive nonsyndromic hearing loss 8 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.0010
DANN
Benign
0.25
PhyloP100
-3.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8130564; hg19: chr21-43805656; COSMIC: COSV52300140; COSMIC: COSV52300140; API